bimekizumab data shows sustained benefits in hidradenitis suppurativa
3rd November 2025 Uncategorised 0
Three-year trial results reveal long-term improvements in pain and lesion resolution

More: bimekizumab data shows sustained benefits in hidradenitis suppurativa
Source: News
